Familial reducing body myopathy
- PMID: 16919903
- DOI: 10.1016/j.braindev.2006.06.010
Familial reducing body myopathy
Abstract
Reducing body myopathy (RBM) is a rare pathologically defined myopathy characterized by the presence of inclusion bodies which are abnormally stained by menadione-nitroblue-tetrazolium. The clinical symptoms vary widely as to the age of onset, disease progression and severity. Among the many reported patients, there have been only three families with this disorder, showing a manifold of clinicopathological features in each family. We report a fourth family with RBM affecting a boy and his mother. The proband (boy) began to have difficulty putting on his trousers at age 10years and difficulty arising from a chair at 11years. His spine was rigid. His mother, on the other hand, noticed foot-drop at the age 29, but the clinical course was rapidly progressive, and she was wheelchair-bound at 34years. Both patients had generalized muscle weakness and atrophy and with mild CK elevation. Muscle pathology was characterized by the presence of atrophic fibers with reducing bodies in some areas. As these patients demonstrate, clinical symptoms in RBM are very variable, even within the same family. There are no specific clinical characteristics distinctive to RBM, thus further studies are necessary to characterize this disorder both clinically and pathologically.
Similar articles
-
[Reducing body myopathy--a case report].Rinsho Shinkeigaku. 1992 Jan;32(1):62-7. Rinsho Shinkeigaku. 1992. PMID: 1321016 Review. Japanese.
-
Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: identification of a second LIM domain mutation in FHL1.Neuropediatrics. 2010 Feb;41(1):43-6. doi: 10.1055/s-0030-1254101. Epub 2010 Jun 22. Neuropediatrics. 2010. PMID: 20571991
-
Nucleolar characteristics of reducing bodies in reducing body myopathy.Acta Neuropathol. 2004 Mar;107(3):265-71. doi: 10.1007/s00401-003-0806-y. Epub 2004 Jan 20. Acta Neuropathol. 2004. PMID: 14735304
-
Polysaccharide storage myopathy--case report and literature review.Clin Neuropathol. 2005 May-Jun;24(3):126-32. Clin Neuropathol. 2005. PMID: 15943164 Review.
-
Ultrastructural detection of DNA fragmentation in myonuclei of fatal reducing body myopathy.Acta Neuropathol. 2004 May;107(5):439-42. doi: 10.1007/s00401-004-0831-5. Epub 2004 Feb 18. Acta Neuropathol. 2004. PMID: 14986028
Cited by
-
Intermitochondrial cement (nuage) in a spermatocytic seminoma: comparison with classical seminoma and normal testis.Virchows Arch. 2008 Aug;453(2):189-96. doi: 10.1007/s00428-008-0610-0. Epub 2008 Apr 19. Virchows Arch. 2008. PMID: 18425535
-
Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy.J Clin Invest. 2008 Mar;118(3):904-12. doi: 10.1172/JCI34450. J Clin Invest. 2008. PMID: 18274675 Free PMC article.
-
Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1.Brain. 2009 Feb;132(Pt 2):452-64. doi: 10.1093/brain/awn325. Epub 2009 Jan 29. Brain. 2009. PMID: 19181672 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials